Cellarity IPO
Cellarity is a biotechnology company that uses artificial intelligence and machine learning to analyze cellular behavior and develop new drugs. The company's platform examines how cells function as dynamic systems to identify novel therapeutic targets and accelerate drug discovery.
What We Know
Cellarity has raised significant venture funding, including a $123 million Series B round in 2021. The company was founded by flagship Pioneering and has developed partnerships with pharmaceutical companies to advance its cell-centric drug discovery platform. While the company has achieved notable milestones in AI-driven drug discovery, no IPO timeline or plans have been publicly announced. The company continues to advance its technology platform and therapeutic pipeline while remaining privately held.
Frequently Asked Questions
Has Cellarity had an IPO?
No, Cellarity has not had an IPO and remains a private company. The company has raised venture funding but has not announced any plans to go public.
When is the Cellarity IPO date?
No IPO date has been announced for Cellarity. The company continues to operate privately with no confirmed public market timeline. Sign up for alerts to stay informed.
How can I buy Cellarity stock?
Cellarity stock is not currently available for purchase as the company remains private. Shares may only be accessible through private markets or accredited investor channels. Sign up for alerts to stay informed.
Stay Updated on the Cellarity IPO
Get real-time alerts when Cellarity files for an IPO, prices shares, or begins trading.
Get IPO Alerts